These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

258 related items for PubMed ID: 16213152

  • 1. Modern diagnostics in acute leukemias.
    Haferlach T, Kern W, Schnittger S, Schoch C.
    Crit Rev Oncol Hematol; 2005 Nov; 56(2):223-34. PubMed ID: 16213152
    [Abstract] [Full Text] [Related]

  • 2. Diagnostic pathways in acute leukemias: a proposal for a multimodal approach.
    Haferlach T, Bacher U, Kern W, Schnittger S, Haferlach C.
    Ann Hematol; 2007 May; 86(5):311-27. PubMed ID: 17375301
    [Abstract] [Full Text] [Related]

  • 3. Predictive factors of relapse and survival in childhood acute myeloid leukemia: role of minimal residual disease.
    Rizzari C, Cazzaniga G, Coliva T, De Angelis C, Conter V.
    Expert Rev Anticancer Ther; 2011 Sep; 11(9):1391-401. PubMed ID: 21929313
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Minimal residual disease in childhood acute leukemias].
    Pawińska K, Balwierz W, Baran J.
    Przegl Lek; 2006 Sep; 63(1):41-3. PubMed ID: 16892899
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Immunophenotyping in acute leukemia: detection of minimal residual disease].
    Pálóczi K, Nahajevszky S, Jakab K, Regéczy N, Gopcsa L, László E, Földi J.
    Orv Hetil; 2000 Nov 12; 141(46):2487-92. PubMed ID: 11126681
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Monitoring of minimal residual disease in acute myeloid leukemia.
    Kern W, Schoch C, Haferlach T, Schnittger S.
    Crit Rev Oncol Hematol; 2005 Nov 12; 56(2):283-309. PubMed ID: 16213150
    [Abstract] [Full Text] [Related]

  • 10. [Multidisciplinary diagnostics in acute leukemia].
    Hokland P, Pedersen B, Bendix K, Koch JE, Pallisgaard N.
    Ugeskr Laeger; 1998 Sep 14; 160(38):5473-8. PubMed ID: 9763918
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Modern diagnostics in chronic myeloproliferative diseases (CMPDs).
    Haferlach T, Kern W, Schnittger S, Schoch C.
    Ann Hematol; 2004 Sep 14; 83 Suppl 1():S59-61. PubMed ID: 15124674
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Diagnosis and genetic subtypes of leukemia combining gene expression and flow cytometry.
    Basso G, Case C, Dell'Orto MC.
    Blood Cells Mol Dis; 2007 Sep 14; 39(2):164-8. PubMed ID: 17588788
    [Abstract] [Full Text] [Related]

  • 17. Role of gene expression profiling for diagnosing acute leukemias.
    Kern W, Kohlmann A, Schnittger S, Schoch C, Haferlach T.
    Rev Clin Exp Hematol; 2005 Jun 01; 9(1):E1. PubMed ID: 16027103
    [Abstract] [Full Text] [Related]

  • 18. Molecular diagnostics in acute leukemias.
    Bacher U, Schnittger S, Haferlach C, Haferlach T.
    Clin Chem Lab Med; 2009 Jun 01; 47(11):1333-41. PubMed ID: 19817644
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Monitoring of minimal residual disease in acute myeloid leukemia.
    Kern W, Haferlach C, Haferlach T, Schnittger S.
    Cancer; 2008 Jan 01; 112(1):4-16. PubMed ID: 18000811
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.